UnknownPhase 2NCT01739517
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
Studying Parenteral nutrition-associated cholestasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amarnath, Rathna, M.D.
- Principal Investigator
- Terra R Varner, PharmDPalmetto Health Children's Hospital
- Intervention
- Omegaven Therapy(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 1 years · All sexes
- Timeline
- 2009 – 2013
Study locations (1)
- Palmetto Health Children's Hospital, Columbia, South Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01739517 on ClinicalTrials.govOther trials for Parenteral nutrition-associated cholestasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06274788Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentFresenius Kabi
- RECRUITINGPHASE4NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsFresenius Kabi
See all trials for Parenteral nutrition-associated cholestasis →